Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Grant or award Chief Executive Officer acquired 217,500 shares (grant or award)
  2. 4 Grant or award Principal Accounting Officer acquired 55,555 shares (grant or award)
  3. 4 Grant or award CFO & Chief Business Officer acquired 44,567 shares (grant or award)
  4. 4 Open-market sale Principal Accounting Officer sold 9,446 shares at an average $2.61 ($24,666)
  5. 4 Open-market sale CFO & Chief Business Officer sold 29,251 shares at $2.66 ($77,948)
  6. 4 Open-market sale Chief Executive Officer sold 72,606 shares at $2.66 ($193,473)
  7. 4 Gift Chief Executive Officer gave 1,050,000 shares (gift)
  8. 4 Grant or award Principal Accounting Officer acquired 20,000 shares (grant or award)
  9. 4 Grant or award Director acquired 28,700 shares (grant or award)
  10. 4 Grant or award Director acquired 28,700 shares (grant or award)
  11. 4 Grant or award Director acquired 28,700 shares (grant or award)
  12. 4 Grant or award Director acquired 28,700 shares (grant or award)
  13. 4 Grant or award Director acquired 28,700 shares (grant or award)
  14. 4 Grant or award Director acquired 28,700 shares (grant or award)
  15. 4 Grant or award Director acquired 28,700 shares (grant or award)
  16. 4 Grant or award Director acquired 10,833 shares (grant or award)
  17. 4 Open-market sale Chief Executive Officer sold 87,216 shares at $1.97 ($172,191)
  18. 4 Open-market sale Principal Accounting Officer sold 9,184 shares at an average $1.94 ($17,813)
  19. 4 Open-market sale CFO & Chief Business Officer sold 19,360 shares at $1.97 ($38,221)
  20. 4 Planned sale Principal Accounting Officer sold 1,820 shares at $2.65 ($4,823)

Page 1 of 16 · 301 filings